Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1993 4
1994 4
1995 5
1996 1
1997 1
1998 1
2000 1
2001 3
2002 5
2003 4
2004 2
2005 8
2006 1
2007 1
2008 2
2009 5
2010 8
2011 4
2012 4
2013 1
2014 2
2016 2
2017 2
2018 1
2019 1
2020 2
2024 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

68 results

Results by year

Filters applied: . Clear all
Page 1
[Active surveillance for renal cell carcinoma].
Doehn C, Witzsch U, Siebels M. Doehn C, et al. Among authors: siebels m. Aktuelle Urol. 2012 Jul;43(4):243-9. doi: 10.1055/s-0032-1321828. Epub 2012 Aug 6. Aktuelle Urol. 2012. PMID: 22869494 Review. German.
Therapeutic approaches in metastatic renal cell carcinoma.
Staehler M, Rohrmann K, Bachmann A, Zaak D, Stief CG, Siebels M. Staehler M, et al. Among authors: siebels m. BJU Int. 2005 Jun;95(8):1153-61. doi: 10.1111/j.1464-410X.2005.05537.x. BJU Int. 2005. PMID: 15877725 Review. No abstract available.
Pathophysiology of hypertensive renal damage.
Ritz E, Fliser D, Siebels M. Ritz E, et al. Among authors: siebels m. Am J Hypertens. 1993 Jul;6(7 Pt 2):241S-244S. doi: 10.1093/ajh/6.7.241s. Am J Hypertens. 1993. PMID: 8398007 Review.
Immunotherapy in metastatic renal cell carcinoma.
Rohrmann K, Staehler M, Haseke N, Bachmann A, Stief CG, Siebels M. Rohrmann K, et al. Among authors: siebels m. World J Urol. 2005 Jul;23(3):196-201. doi: 10.1007/s00345-004-0470-4. Epub 2005 Apr 2. World J Urol. 2005. PMID: 15806434 Review.
Cell-based vaccines for renal cell carcinoma: genetically-engineered tumor cells and monocyte-derived dendritic cells.
Frankenberger B, Regn S, Geiger C, Noessner E, Falk CS, Pohla H, Javorovic M, Silberzahn T, Wilde S, Buchner A, Siebels M, Oberneder R, Willimsky G, Pezzutto A, Blankenstein T, Schendel DJ. Frankenberger B, et al. Among authors: siebels m. World J Urol. 2005 Jul;23(3):166-74. doi: 10.1007/s00345-005-0505-5. Epub 2005 Jul 5. World J Urol. 2005. PMID: 15997395 Review.
Sorafenib in advanced clear-cell renal-cell carcinoma.
Escudier B, Eisen T, Stadler WM, Szczylik C, Oudard S, Siebels M, Negrier S, Chevreau C, Solska E, Desai AA, Rolland F, Demkow T, Hutson TE, Gore M, Freeman S, Schwartz B, Shan M, Simantov R, Bukowski RM; TARGET Study Group. Escudier B, et al. Among authors: siebels m. N Engl J Med. 2007 Jan 11;356(2):125-34. doi: 10.1056/NEJMoa060655. N Engl J Med. 2007. PMID: 17215530 Free article. Clinical Trial.
68 results